Silence Therapeutics plc (SLN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Silence Therapeutics plc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.24x | -2.34x | -3.90x | -2.69x | -13.28x | -13.49x |
| P/B Ratio | 4.61x | 0.79x | 7.68x | 6.13x | 61.38x | 48.45x |
| P/S Ratio | 513.72x | 2.45x | 6.65x | 6.25x | 42.15x | 80.11x |
| Profitability | ||||||
| Gross Margin | 61.5% | 72.7% | 59.3% | 37.8% | 39.9% | 31.3% |
| Operating Margin | -16056.0% | -146.4% | -195.5% | -281.9% | -369.0% | -654.3% |
| Net Margin | -15851.9% | -104.7% | -170.5% | -232.4% | -317.4% | -594.0% |
| EBITDA Margin | -15956.7% | -113.2% | -196.2% | -279.1% | -365.9% | -648.5% |
| Liquidity | ||||||
| Current Ratio | 8.72x | 11.14x | 4.62x | 4.41x | 5.69x | 2.99x |
| Quick Ratio | 8.72x | 11.14x | 4.62x | 4.41x | 5.69x | 2.99x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.02x | 0.02x | 0.02x | 0.04x |
YoY = year-over-year change. Source: FMP..